Yung-Tsai Lee

Dr. Yung-Tsai Lee

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Chin-Sheng LinChin-Sheng Lin
Chin-Sheng Lin
YLYung-Tsai Lee
Yung-Tsai Lee
Wen-Hui FangWen-Hui Fang
Wen-Hui Fang
YLYu-Sheng Lou
Yu-Sheng Lou
FKFeng-Chih Kuo
Feng-Chih Kuo
CHIN LINCHIN LIN
CHIN LIN
Background: glycated hemoglobin (HbA1c) provides information on diabetes mellitus (DM) management. Electrocardiography (ECG) is a noninvasive test of cardiac activity that has been determined to be related to DM and its complications. This study developed a deep learning model (DLM) to estimate HbA1c via ECG. Methods: there were 104,823 ECGs with corresponding HbA1c or fasting glucose which were utilized to train a DLM for calculating ECG-HbA1c. Next, 1539 cases from outpatient departments and health examination centers provided 2190 ECGs for initial validation, and another 3293 cases with their first ECGs were employed to analyze its contributions to DM management. The primary analysis was used to distinguish patients with and without mild to severe DM, and the secondary analysis was to explore the predictive value of ECG-HbA1c for future complications, which included all-cause mortality, new-onset chronic kidney disease (CKD), and new-onset heart failure (HF). Results: we used a gender/age-matching strategy to train a DLM to achieve the best AUCs of 0.8255 with a sensitivity of 71.9% and specificity of 77.7% in a follow-up cohort with correlation of 0.496 and mean absolute errors of 1.230. The stratified analysis shows that DM presented in patients with fewer comorbidities was significantly more likely to be detected by ECG-HbA1c. Patients with higher ECG-HbA1c under the same Lab-HbA1c exhibited worse physical conditions. Of interest, ECG-HbA1c may contribute to the mortality (gender/age adjusted hazard ratio (HR): 1.53, 95% conference interval (CI): 1.08–2.17), new-onset CKD (HR: 1.56, 95% CI: 1.30–1.87), and new-onset HF (HR: 1.51, 95% CI: 1.13–2.01) independently of Lab-HbA1c. An additional impact of ECG-HbA1c on the risk of all-cause mortality (C-index: 0.831 to 0.835, p < 0.05), new-onset CKD (C-index: 0.735 to 0.745, p < 0.01), and new-onset HF (C-index: 0.793 to 0.796, p < 0.05) were observed in full adjustment models. Conclusion: the ECG-HbA1c could be considered as a novel biomarker for screening DM and predicting the progression of DM and its complications.

23 October 2024 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
TWTing-Wei Wang
Ting-Wei Wang
YTYun-Hsuan Tzeng
Yun-Hsuan Tzeng
KWKuan-Ting Wu
Kuan-Ting Wu
HLHo-Ren Liu
Ho-Ren Liu
Jia-Sheng HongJia-Sheng Hong
Jia-Sheng Hong
YWYu-Te Wu
Yu-Te Wu

16 May 2024 in Aging
Verified
Journal Article
Open access
PDF file
YLYu-Ting Lin
Yu-Ting Lin
CLChin-Sheng Lin
Chin-Sheng Lin
CTChien-Sung Tsai
Chien-Sung Tsai
DTDung-Jang Tsai
Dung-Jang Tsai
YLYu-Sheng Lou
Yu-Sheng Lou
CHIN LINCHIN LIN
CHIN LIN
Background: Valvular heart disease (VHD) is becoming increasingly important to manage the risk of future complications. Electrocardiographic (ECG) changes may be related to multiple VHDs, and (AI)-enabled ECG has been able to detect some VHDs. We aimed to develop five deep learning models (DLMs) to identify aortic stenosis, aortic regurgitation, pulmonary regurgitation, tricuspid regurgitation, and mitral regurgitation. Methods: Between 2010 and 2021, 77,047 patients with echocardiography and 12-lead ECG performed within 7 days were identified from an academic medical center to provide DLM development (122,728 ECGs), and internal validation (7,637 ECGs). Additional 11,800 patients from a community hospital were identified to external validation. The ECGs were classified as with or without moderate-to-severe VHDs according to transthoracic echocardiography (TTE) records, and we also collected the other echocardiographic data and follow-up TTE records to identify new-onset valvular heart diseases. Results: AI-ECG adjusted for age and sex achieved areas under the curves (AUCs) of >0.84, >0.80, >0.77, >0.83, and >0.81 for detecting aortic stenosis, aortic regurgitation, pulmonary regurgitation, tricuspid regurgitation, and mitral regurgitation, respectively. Since predictions of each DLM shared similar components of ECG rhythms, the positive findings of each DLM were highly correlated with other valvular heart diseases. Of note, a total of 37.5–51.7% of false-positive predictions had at least one significant echocardiographic finding, which may lead to a significantly higher risk of future moderate-to-severe VHDs in patients with initially minimal-to-mild VHDs. Conclusion: AI-ECG may be used as a large-scale screening tool for detecting VHDs and a basis to undergo an echocardiography.

20 August 2025 in European Heart Journal - Digital Health
Verified
Journal Article
Open access
CCChiao-Hsiang Chang
Chiao-Hsiang Chang
Chin-Sheng LinChin-Sheng Lin
Chin-Sheng Lin
CLChun-Ho Lee
Chun-Ho Lee
CHIN LINCHIN LIN
CHIN LIN
CLChiao-Chin Lee
Chiao-Chin Lee
DTDung-Jang Tsai
Dung-Jang Tsai
Aims: Early detection of the need for coronary revascularization and timely intervention may reduce fatal events, but limited screening tools often leads to underdiagnosis. The aim of this study is to use a deep learning model (DLM) that utilizes electrocardiography (ECG) and the eXtreme Gradient Boosting (XGBoost) model to predict risk of coronary revascularization in the general population. Methods and results: This study included patients with at least one ECG per patient. The development set comprised 113 451 patients for training a DLM. After excluding patients with elevated troponin I levels and those without follow-up records, the internal validation set consisted of 66 680 patients. The external validation was conducted using data from a community hospital. XGBoost predicted events based on demographic data and ECG features. The primary endpoint was coronary revascularization within 1 year. Model performance was evaluated using the C-index. The DLM stratified patients by risk of coronary revascularization within 1 year. The study included 51% males with a mean age of 53 years, 10% with diabetes, and a revascularization rate of 2.6%. High-risk patients had a hazard ratio of 9.77 (95% CI: 7.63–12.51) compared with low-risk patients. The C-index was 0.825 (95% CI: 0.81–0.84). Combining demographic and AI-ECG data, XGBoost achieved a C-index of 0.884 (95% CI: 0.87–0.89). Comparative C-index analysis revealed significantly different discriminative performance between models (P = 1.110223e−15). Conclusions: The DLM demonstrates ECG's potential as a screening tool for coronary revascularization, enabling opportunistic detection and prompting further evaluation of high-risk patients.

5 November 2024 in Next Research
Verified
Journal Article
Closed access
TWTing-Wei Wang
Ting-Wei Wang
YTYun-Hsuan Tzeng
Yun-Hsuan Tzeng
Jia-Sheng HongJia-Sheng Hong
Jia-Sheng Hong
HLHo-Ren Liu
Ho-Ren Liu
HFHao-Neng Fu
Hao-Neng Fu
YWYu-Te Wu
Yu-Te Wu

24 October 2024 in Journal of Imaging Informatics in Medicine
Verified
Journal Article
Closed access
PDF file
YCYu-Cheng Chen
Yu-Cheng Chen
WFWen-Hui Fang
Wen-Hui Fang
CHIN LINCHIN LIN
CHIN LIN
DTDung-Jang Tsai
Dung-Jang Tsai
CHChih-Wei Hsiang
Chih-Wei Hsiang
YLYung-Tsai Lee
Yung-Tsai Lee